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Characterising the genomic variation and population dynamics of Plasmodium falciparum parasites 
in high transmission regions of Sub-Saharan Africa is crucial to the long-term efficacy of regional 
malaria elimination campaigns and eradication. Whole-genome sequencing (WGS) technologies 
can contribute towards understanding the epidemiology and structural variation landscape of 
P. falciparum populations, including those within the Lake Victoria basin, a region of intense 
transmission. Here we provide a baseline assessment of the genomic diversity of P. falciparum isolates 
in the Lake region of Kenya, which has sparse genetic data. Lake region isolates are placed within the 
context of African-wide populations using Illumina WGS data and population genomic analyses. Our 
analysis revealed that P. falciparum isolates from Lake Victoria form a cluster within the East African 
parasite population. These isolates also appear to have distinct ancestral origins, containing genome-
wide signatures from both Central and East African lineages. Known drug resistance biomarkers were 
observed at similar frequencies to those of East African parasite populations, including the S160N/T 
mutation in the pfap2mu gene, which has been associated with delayed clearance by artemisinin-
based combination therapy. Overall, our work provides a first assessment of P. falciparum genetic 
diversity within the Lake Victoria basin, a region targeting malaria elimination.
Despite decades of research and elimination campaigns, malaria remains a major global health threat and is the 
sixth leading cause of death in low-income countries, with an estimated 228 million cases and ~ 405,000 deaths 
worldwide in 2019  alone1. The Sub-Saharan African region accounts for more than 93% of all cases and deaths, 
with children under five years old disproportionately  affected1. Plasmodium falciparum is the most prevalent and 
deadly malaria parasite in sub-Saharan Africa, as well as the cause of almost all severe disease, including severe 
malarial anaemia and cerebral  malaria2,3. Even with progress over the past few decades, reduction in malaria-
associated deaths has decelerated since 2016 and progress towards global malaria eradication overall has slowed, 
in part due to the emergence and spread of drug resistance in malaria parasites and insecticide resistance in 
their mosquito  vectors1. Due to their isolated geography and distinctive population dynamics, inhabited islands, 
such as those within the Lake Victoria basin, offer unique environments to test malaria elimination  strategies4.
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Studies in low transmission settings have provided valuable insight into malaria elimination strategies that 
may be viable for islands, as well as an increased understanding of the role human movement plays in malaria 
transmission in these  environments5. The implementation of intensive and targeted measures on islands in 
low-transmission settings, including vector control based strategies (e.g. insecticide-treated nets and indoor 
residual spraying) and mass drug administration, has led to malaria elimination in places such as the Maldives 
and Reunion  archipelagos6. Recently, attention has moved to islands in high-transmission regions where there 
is an increased rate of gene flow within and between malaria parasite populations, which may aid in propagat-
ing novel traits detrimental to malaria treatment outcomes and elimination  campaigns4. Past failures of malaria 
elimination campaigns on high-transmission islands, such as Zanzibar and the Comoros archipelago off the coast 
of East Africa, have highlighted the need for a better understanding of the roles human and vector migration play 
in settings with intense transmission patterns, and their impact on parasite population genetics and  structure7. 
The development of methodologies that allow for the amplification of parasite DNA from infections with low 
parasite density, alongside the reduction in costs associated with next-generation whole genome sequencing 
(WGS), has made investigating parasite genomic diversity in malaria endemic settings  attainable8,9.
Malaria transmission and infection risk has decreased in Kenya and cases of the disease are generally not 
seen in high-elevation regions, such as Nairobi, due to the inability of mosquito vectors to survive at such alti-
tudes. Low-elevation regions, however, such as the Lake Victoria basin and coastal regions along the Indian 
Ocean, still struggle with high rates of malaria transmission as they provide ideal breeding habitats for Anopheles 
 mosquitoes10,11. Depending on the season, P. falciparum infection rates in the Lake Victoria basin can exceed 40% 
for those aged 2 to 10 years  old12. Due to the size of Lake Victoria, and its location along three country borders 
with differing government policies concerning the implementation and funding of malaria control programmes, 
applying any targeted vector control in and around Lake Victoria has proven incredibly  difficult4,11. There are 
multiple inhabited islands within the Kenyan territory of Lake Victoria, such as Mfangano island (population 
size 26,000) and Ngodhe island (population size 600–1000), which offer a unique opportunity to study malaria 
elimination strategies and changes in parasite genetic diversity.
To date, there has been limited research in the Lake Victoria region aimed at characterising the genomic 
diversity of the malaria parasites present. Previous research has assessed the genetic diversity through targeted 
genotyping of drug resistance genes or using microsatellite markers to gain insight into population  dynamics4. 
However, such approaches underestimate the overall genetic variation of a population as only a small proportion 
of the genome is  represented13. Consequently, the genomic diversity and population dynamics of malaria parasites 
from islands within the region remain largely unexplored. WGS technologies provide a means for generating a 
comprehensive picture of the epidemiology and structural variation of the P. falciparum populations within the 
Lake Victoria  basin8. Here, to provide a baseline level of genomic diversity within the Lake region, we generated 
WGS data for two islands, as well as the mainland sub-county Suba District (population size: North 124,938; 
South 122,383) and compared the resulting variation to publicly available whole genome sequences, from Kenya 
and the wider African continent through the Pf3K project (https:// www. malar iagen. net/ paras ite/ pf3k). Our 
analysis revealed that P. falciparum isolates from the Lake Victoria region of Kenya have distinct ancestral ori-
gins, with a high proportion tied to Central and East African lineages, and form a distinct sub-group within East 
Africa in population structure analyses. Known drug resistance biomarkers were observed in the Lake Victoria 
isolates at similar frequencies to those of East African parasite populations.
Results
Genome data and multi-clonality. A total of 940,191 high-quality SNPs were identified in the non-
hypervariable regions of the P. falciparum genome. The final dataset comprised 784 isolates from 9 different 
countries in Africa (Supplementary Table  S1), which included those collected in and around Lake Victoria 
(Mfangano island, Ngodhe island, and Suba District; N = 48); Kenya (Kilifi, Kisumu, and Kombewa, N = 134); 
East Africa (Tanzania and Uganda, N = 139); West Africa (The Gambia and Mauritania, N = 159); Central Africa 
(Cameroon, N = 98); South Central Africa (Democratic Republic of the Congo, N = 97); Southeast Africa (Mada-
gascar and Malawi, N = 119). The samples from Lake Victoria were collected across two inhabited islands and 
one mainland site (Supplementary Table S1; Supplementary Fig. S1). The average number of pairwise SNP dif-
ferences, a measure of genetic diversity, were broadly similar within locations around the Lake basin (Mfangano 
island 7900.8; Suba District 8708.1; Kisumu and Kombewa 9224.7).
Multi-clonality was measured using the FWS metric, which assesses within-host diversity in relation to the 
local population diversity to characterise the risk of out-crossing/inbreeding, with monoclonal samples exhibiting 
“high” FWS estimates (i.e. ≥ 0.95)14,15. In the samples collected from Mfangano and Ngodhe islands, a mean FWS 
of 0.944 was observed, with 70.2% of samples exhibiting “high” FWS estimates. When samples from Mfangano 
island and Ngodhe island were combined with samples from Suba District, a mean FWS of 0.940 was observed 
(72.9% ≥ 0.95). Most samples from Mfangano (N = 19) and a handful of samples from Suba district (N = 9) were 
cultured in vitro prior to sequencing, which is consistent with the “high” FWS estimates observed.
Isolates from Kisumu and Kombewa, Kenya had a mean FWS of 0.777 (31.1% ≥ 0.95). The low proportion of 
samples with high FWS scores is generally associated with a high degree of panmixis between the parasites in the 
population and a low population sub-structure. Samples from the Lake Victoria Region (i.e., Mfangano island, 
Ngodhe island, Suba District, Kisumu, Kombewa, and Muleba, Tanzania) and samples from East Africa (i.e., 
Kenya and Tanzania) had mean FWS scores of 0.840 (48.1% ≥ 0.95) and 0.856 (51.5% ≥ 0.95) respectively.
P. falciparum isolates from Lake Victoria form a distinct sub-group within East Africa. A SNP-
based principal components analysis (PCA) and neighbour-joining tree revealed that Lake Victoria isolates (i.e., 
Mfangano island, Ngodhe island, Suba District, Kisumu, and Kombewa) cluster with the East African subpopu-
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lations when compared to larger regional African populations (Fig. 1A,B). To highlight the structure of the East 
African regional subpopulations, a SNP-based neighbour-joining tree and PCA were compiled using samples 
from Kenya, Tanzania, Uganda, and the Lake Victoria isolates. As anticipated, the Lake Victoria samples formed 
a sub-group within the larger East African dataset (Fig. 1C,D). A SNP-based neighbour-joining tree consist-
ing of only samples from Lake Victoria provided a higher resolution of the population dynamics, and demon-
strated that the isolates from the islands and Suba district appear to form a distinct genomic sub-group within 
the larger Lake Victoria population (Fig. 1E,F).
Ancestral admixture analysis provides insight into the ancestral origins of Lake Victoria sub-
population. Spatial modelling of allele sharing using genome-wide SNPs and geographical coordinates 
was used to evaluate the ancestral origins of Lake Victoria isolates alongside the regional African populations. 
This ancestral admixture analysis revealed that Lake Victoria isolates contain differing proportions of ancestral 
genome pieces compared with East African isolates, where the optimum number of ancestral populations (K 
value) is estimated to be 5 (K1-K5) (Fig. 2). The K5 ancestral population appears to be linked to Central African 
isolates (Cameroon-like, 88.3%), K4 is linked to East Africa (Kenya-like, 83.0%; Tanzania-like 73.0%), and the 
K3 population appears to be linked to West Africa (Gambia-like, 78.0%). Lake Victoria isolates appeared to share 
a high proportion of their ancestral genome with East (K4, 62.3%) and Central (K5, 27.2%) African isolates. Fur-
ther, a high proportion resemble Ugandan isolates, in addition to those from Kenya or Tanzania (Supplementary 
Fig. S1). As anticipated, the ancestry of Ethiopia, the Horn of Africa, was quite distinct compared to the other 
regional African populations, comprising mainly of the K1 ancestral population (92.7%), with limited ancestry 
in Lake Victoria isolates (2.9%).
Analysis of IBD reveals differences within the Lake Victoria subpopulations. Analysis of 
identity-by-descent (IBD) was performed to understand the chromosome-level structure within subpopula-
tions in and around Lake Victoria, Kenya. The proportion of pairs identical by descent at each SNP for all 
isolates was used to determine the extent of genomic relatedness. Isolates from Kisumu and Kombewa exhib-
ited the highest fractions of pairwise IBD across the genome (Kisumu: median = 0.211, range = 0.182–0.238; 
Kombewa: median = 0.121, range = 0.069–0.200), reflecting high relatedness; while isolates from Mfangano and 
Suba exhibited lower fractions of IBD (Mfangano: median = 0.032, range = 0.018–0.142; Suba: median = 0.055, 
range = 0.055–0.132) (Supplementary Table S2). These lower fractions of IBD in the Mfangano and Suba isolates 
would suggest that relatedness is low, however their laboratory culture may be confounding these results as it 
is anticipated that samples in these populations would have high fractions of IBD across the genome. Examples 
of genome-wide IBD along each chromosome for individual sample sites and for regions across Africa are pre-
sented (Supplementary Fig. S2).
The top 5% of IBD positions in the island isolates from Lake Victoria were distributed across 31 regions on 
nine chromosomes 1,3,5,6,7,8,11,12,and13 (Supplementary Table S3). The region on chromosome 8 encompassed the 
hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase gene (Pfdhps, PF3D7_0810800), linked 
to Sulfadoxine–pyrimethamine (SP) antimalarial resistance. The top 5% of IBD positions in the mainland isolates 
from Lake Victoria were distributed across 13 regions on seven chromosomes 3,6,7,8,12,13,and14. While the top 5% 
of IBD positions in East African isolates included 35 regions across eight chromosomes 3,4,5,6,7,8,12,and13. The IBD 
region on chromosome 7 encompassed the chloroquine resistance transporter gene (Pfcrt, PF3D7_0709000), while 
the region on chromosome 8 included Pfdhps linked to SP resistance.
Population differentiation between Lake Victoria isolates and others. Fixation index (FST) analy-
ses were performed to identify SNPs associated with the distinct subpopulations within the Lake Victoria region, 
and between other regional populations of the African continent. A genome-wide comparison of the differ-
ences in allele frequencies between samples collected from Suba District to those from Kisumu and Kombewa, 
identified 90 SNPs with an FST value of 0.5 or higher, suggesting some degree of genetic differentiation between 
these two subpopulations. In comparison, an analysis comparing Mfangano island with those from Kisumu and 
Kombewa identified 40 SNPs with an FST value greater than 0.5. A final comparison between samples collected 
from Mfangano island with those collected from Suba District resulted in 80 SNPs with an FST value of 0.5 or 
higher being identified. Across all island comparisons, most SNPs had an FST value of 0.5 or lower which suggests 
there is still frequent and consistent interbreeding between these populations. The lower number of significant 
SNPs for Mfangano comparisons may be explained by lower sequencing coverage leading to missing SNP geno-
types, likely due to the lower parasite DNA concentrations often seen in the asymptomatic infections from which 
these samples were acquired. To identify genetic markers with the potential to be used to differentiate between 
isolates within the Lake Victoria region, and with populations across Africa, SNPs with an FST value of 1 (imply-
ing complete population differentiation) were compiled (Table 1). These may be used to determine the origin of 
a sample and monitor circulating parasites.
Identification of mutations in drug resistance candidate genes. Non-synonymous SNP mutations 
in resistance-associated genes were identified in historical isolates from coastal (e.g., Suba district) and island 
parasite populations (e.g., Mfangano island) within Lake Victoria. The frequencies of these mutations in the 
Lake Victoria isolates were compared to frequencies observed in East African parasite populations (e.g., Tanza-
nia and Kenya) and West African populations (e.g., Mauritania and The Gambia).
Resistance markers for chloroquine and SP were observed in the Lake Victoria isolates at similar frequencies 
seen in the East African populations, and slightly higher frequencies than in West African populations (Sup-
plementary Table S4). The Pfcrt K76T mutation, often used as the main marker of chloroquine resistance, was 
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observed in 17.9% (N = 29) of the Lake Victoria isolates, 16.7% (N = 228) of the East African isolates, and 13.0% 
(N = 159) of West African isolates. Mutations F938Y and D1246Y in Pfmdr1 have been associated with resistance 
to chloroquine, with D1246Y linked to lumefantrine. These mutations were observed in low frequencies in the 
Figure 1.  Plasmodium falciparum isolates from Lake Victoria (LV) form a distinct sub-group within East 
Africa. Principal component analysis (PCA) and neighbour-joining (NJ) trees generated from pairwise genetic 
distance matrices containing 940,191 quality filtered SNPs from 784 P. falciparum isolates. (A,B) A PCA plot 
and neighbour-joining tree for 784 isolates from East (EAF), Central (CAF), South Central (SCAF), Southeast 
(SAF), and West (WAF) Africa, LV mainland and islands. (C,D) A PCA plot and NJ tree for 321 isolates from 
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Lake Victoria (F938Y 3.6%; D1246Y 7.1%) and East African isolates (7.6%; 11.3%), but at higher frequencies in 
the West African populations (22.2%; 31.2%).
Pfdhfr mutations associated with SP resistance were observed at very high frequencies in both the Lake Victo-
ria and East African isolates, with 100% of the Lake Victoria isolates containing the N51I and S108N mutations, 
compared to 93.3% and 99.5%, respectively, in the East African isolates. The C59R (Lake Victoria 92.9%; East 
Africa 87%) and I164L (Lake Victoria 7.1%; East Africa 2.2%) mutations were also present. The Pfdhfr mutations 
were observed at similar frequencies in the West African parasite populations, however the I164L polymorphism 
was not observed. The K540E mutation on Pfdhps associated with SP resistance was observed in 100% of the 
Lake Victoria isolates, higher than East (85.8%) and West (30.0%) African isolates.
No known mutations on Pfk13 associated with artemisinin resistance were observed in the Lake Victoria or 
East African isolates. The S160N/T polymorphism on Pfap2mu, believed to be associated with delayed clearance 
by artemisinin combination therapies (ACTs), was observed in 17.8% (S160N) of the Lake Victoria isolates, 17.4% 
(S160N/T) of the East African isolates, and 38.0% (S160N) in West African  isolates16,17.
Regions under selection in Lake Victoria and other subpopulations. Analysis of haplotype struc-
ture within the Lake Victoria isolates was performed to determine genomic regions responding to positive 
directional selection, identified as having high local homozygosity relative to the neutral expectation. SNPs on 
genes under selective pressure in a distinct subpopulation were identified using the integrated haplotype score 
Figure 2.  Genome-wide admixture ancestry proportions for regional P. falciparum populations across the 
African continent. (A) Geographic map of ancestry coefficients using K = 5 ancestral populations across Africa. 
(B) Ancestry per isolate (rows) for each regional population (columns). (C) Principal component analysis 
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(iHS) test statistic, whereas cross-population selective pressures were identified by the XP-EHH metric, which 
contrasts extended haplotype homozygosity (EHH) profiles between populations (Supplementary Fig. S3, Sup-
plementary Table S5, Supplementary Table S6).
As anticipated, the most common SNPs under selective pressure were those on genes associated with the host 
immune response and immune evasion. Within the Mfangano isolates there were 4 genes of interest identified 
with SNPs that had significant iHS values ((−  log10[1–2|ΦiHS–0.5|]) > 4.0), including: P. falciparum apical mem-
brane protein 1 (Pfama1), one of the leading malaria vaccine candidates, merozoite surface protein 3 (Pfmsp3), 
associated with erythrocyte invasion and host immunity, and the Peptidase family C50 which are associated 
with the pathogenicity of P. falciparum through parasite immune evasion or invasion of host cells (Supplemen-
tary Fig. S3, Supplementary Table S5). In isolates from Suba district, only a Plasmodium RNA of unknown 
function (RUF6) was identified to have significant iHS values. Genes of interest within isolates collected from 
islands in Lake Victoria (e.g., Mfangano and Ngodhe island) included C50, Plasmepsin X (PMX), a mediator 
of parasite egress and invasion, Pfmsp3, and Pfama1. Pfama1 and Pfmsp3 are vaccine candidates. There was no 
strong evidence of positive selection (iHS values < 4.0) in two other key candidates (reticulocyte-binding protein 
homologue-5 (PfRH5), circumsporozoite protein (PfCSP)).
Cross-population analysis of isolates from the Lake Victoria islands with isolates from the Lake Victoria 
mainland (e.g., Suba, district and Kisumu, Kenya; Muleba, Tanzania) identified 2 genes with significant XP-
EHH values ((-log10[p-value]) > 5.0), PMX and the Duffy binding-like merozoite surface protein 2 (Pfdblmsp2) 
(Supplementary Fig. S3, Supplementary Table S6). Isolates from the Lake Victoria islands were also compared 
to isolates collected from East Africa (e.g., Kenya, Tanzania, and Uganda) and 3 genes were identified, including 
Pfdblmsp2, PMX, and a cell traversal protein for ookinetes and sporozoites (CelTOS) which is a conserved anti-
gen believed to have protective potential. Isolates from the Lake Victoria islands and mainland were compared 
to West and Central Africa to assess regional differences in selection pressures. When compared to West Africa, 
PMX was found to have significant XP-EHH values in the Lake Victoria isolates. When isolates from the Lake 
Victoria mainland were compared to West Africa, 4 genes were identified to have significant XP-EHH values, 
including several genes associated with drug resistance, including pro-drug activation and resistance esterase 
Table 1.  Genetic markers for population differentiation between Lake Victoria isolates and other sub-
populations according to the fixation index statistics (FST). SNPs with an FST value of 1. Ref = Pf3D7 reference 
allele; *Lake Victoria = Mfangano, Ngodhe, Suba, Kisumu, and Kombewa; East Africa = Kenya, Tanzania, 
and Uganda; Central Africa = Cameroon; South Central Africa = Democratic Republic of Congo; Southeast 
Africa = Malawi and Madagascar; West Africa = The Gambia and Mauritania.
Chromosome Position Ref Population 1 (allele) Population 2 (allele)
14 2,468,958 A Mfangano, Ngodhe & Suba (A) Kisumu & Kombewa (G/AG)
6 67,235 T Mfangano (A) Kisumu & Kombewa (T)
14 2,468,958 A Mfangano (A) Kisumu & Kombewa (G/AG)
4 1,081,227 T Suba (T) Kisumu & Kombewa (G)
9 1,126,737 A Suba (A) Kisumu & Kombewa (T)
10 838,875 A Suba (G) Kisumu & Kombewa (A)
11 250,576 A Suba (A) Kisumu & Kombewa (G)
3 1,004,970 C Mfangano (C) Suba (T)
3 1,004,977 T Mfangano (T) Suba (C)
5 184,986 G Mfangano (G) Suba (A)
7 701,509 G Mfangano (G) Suba (A)
11 966,450 C Mfangano (C) Suba (T)
13 422,582 T Mfangano (T) Suba (G)
14 1,242,566 T Mfangano (T) Suba (A)
5 1,116,502 T Lake Victoria (T) Kilifi, Kenya (A)
6 59,375 T Lake Victoria (T) Kenya, Tanzania and Uganda (G)
6 59,378 C Lake Victoria (C) Kenya, Tanzania and Uganda (A)
14 2,468,951 A Lake Victoria (A) Kenya, Tanzania and Uganda (T)
5 1,116,502 T Lake Victoria (T) Cameroon (A)
6 68,360 C Lake Victoria (T) Cameroon (C)
14 2,468,958 A Lake Victoria (A) Cameroon (G/AG)
5 1,116,502 T Lake Victoria (T) Democratic Republic of Congo (A)
6 68,360 C Lake Victoria (T) Democratic Republic of Congo (C)
14 2,468,958 A Lake Victoria (A) Democratic Republic of Congo (G)
14 2,468,958 A Lake Victoria (A) Malawi and Madagascar (G)
6 68,229 T Lake Victoria (A) The Gambia and Mauritania (T)
14 2,468,951 A Lake Victoria (A) The Gambia and Mauritania (T)
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(PARE; pepstatin), Pfcrt (chloroquine), and Pfdhps (SP), as well as CCR4-associated factor 1 (CAF1), an egress 
and invasion protein.
Discussion
Advances in next-generation sequencing technologies have provided an increasingly viable means for exploring 
the genomic variation and population dynamics of malaria parasites in high-transmission regions, where reduc-
tion in incidence rates have slowed in recent years. Such platforms can generate comprehensive snapshots of a 
region’s epidemiology and structural  variation1,14,18. Due to their isolated geography and distinctive population 
dynamics, islands in high-transmission regions offer a unique environment to study parasite gene flow and test 
malaria control  strategies4,5. Here, we have provided a baseline level of genomic diversity within the Kenyan Lake 
Victoria basin that has revealed the presence of known drug resistance biomarkers. P. falciparum isolates from 
Lake Victoria form a cluster within the East African subpopulation, and island and Suba District isolates appear 
to form their own sub-group within the Lake Victoria basin. Further, the Lake Victoria parasite populations have 
central and east African lineage ancestry.
Low levels of genetic differentiation between the island sample sites are typically assumed to be due to the 
high levels of human traffic between the sampling sites. However, comparisons of isolates obtained from the 
Lake Victoria basin have highlighted distinct sub-grouping  dynamics4. Although the movement of people and 
vectors is common around the islands and adjacent mainland, movement to and from other sections of the 
lake is limited by transportation infrastructure and geography. A handful of communities on the large island 
of Mfangano are somewhat isolated from communities with frequent migration to and from the mainland due 
to their rough terrain and limited access routes, which may account for some degree of differentiation between 
Mfangano parasites and those from the wider Lake Victoria basin.
Admixture analysis revealed insights into the ancestral origins of the Lake Victoria isolates within the wider 
African continent context. Lake Victoria isolates contained high proportions of ancestral genome fragments 
associated with Central African and East African populations. This analysis aligns well with the current prevail-
ing P. falciparum origin hypothesis, suggesting that malaria first emerged in Central Africa before spreading 
out through early human migration, with subsequent more recent migration events throughout the African 
 continent19. A closer look at the admixture ancestry of specific country populations demonstrated that isolates 
collected within the Lake Victoria basin (e.g., Kisumu, Kombewa, Mfangano, Ngodhe, and Suba from Kenya) 
appeared to share similar cumulative proportions of ancestral genome fragments as isolates from Uganda, but 
differed from the proportions observed in Kenyan and Tanzanian isolates. Future investigations with a greater 
density of sampling, including the integration of parasite and human genomics, could provide insights into the 
co-evolution of host–pathogen and be linked to ethnohistory.
Population differentiation (FST) analysis identified SNPs specific to the Lake Victoria subpopulations and 
African regional populations. These SNPs have the potential to be utilised in a molecular surveillance tool to 
determine the main routes of transmission and parasite migration. Population-specific SNPs were identified 
within the characterised nuclear genomes and offer a high degree of specificity on a smaller spatial scale, gener-
ally to the country of origin. These markers could be combined with population-specific organellar SNPs, which 
provide regional or continental level resolution, as well as SNPs on merozoite surface protein genes (e.g. Pfmsp1 
and Pfmsp2), which can be used to assess transmission  intensity20–22. Further sample collection and characteri-
zation of P. falciparum genome data from the Lake Victoria region, alongside a robust African dataset, would 
be needed to generate a panel of SNPs with the degree of resolution needed to generate an effective molecular 
surveillance tool.
Analysis of the haplotype structure in the Lake Victoria isolates identified significant SNPs under selective 
pressure on genes associated with the host immune response and parasite immune evasion, such as Pfama1, 
Pfmsp3, and PMX. Pfama1 is a leading malaria vaccine candidate due to the essential role it plays in parasite 
invasion of erythrocytes. Pfama1 and other vaccine candidate genes have been found to be under balancing 
 selection23. PMX is another important mediator of parasite invasion and  egress24,25. Pfmsp3 is an attractive vaccine 
candidate due to its role in mediating the host immune response to Plasmodium  parasites26. Cross-population 
analysis comparing parasite populations from the Lake Victoria islands with the local mainland and East African 
populations identified SNPs on genes associated with immune evasion, host immune response, and sporozoite 
traversal (e.g., Pfdblmsp2, PMX, CelTOS). Duffy-binding-like domains are associated with a variety of pathogenic 
phenotypes in P. falciparum and are attractive malaria vaccine candidates given their crucial involvement in 
erythrocyte invasion. While CelTOS is believed to mediate transmission to mosquito and vertebrate  hosts27,28.
Analysis of identity-by-descent (IBD) revealed that isolates from Kisumu and Kombewa exhibited the high-
est fractions of pairwise IBD across the genome, reflecting high relatedness. Isolates from Mfangano and Suba 
exhibited lower fractions of IBD, which would suggest low relatedness between these isolates. However, given 
their close geographical proximity and the continuous movement of people between these sites, the culturing of 
some isolates prior to sequencing may be confounding these  results29. The Pfdhps gene, known to be associated 
with resistance to SP, was found to be in the top 5% of IBD positions in island isolates from Lake Victoria, sug-
gesting this gene is being highly conserved in this population, likely due to the continued use of SP as a method 
of intermittent preventative treatment in pregnancy (IPTp)30,31.
Malaria treatment strategies within this region and across the African continent have been tailored to preserve 
the efficacy of existing antimalarial drugs, while further reducing parasite incidence  rates32. ACTs are the current 
first-line treatment for uncomplicated malaria in Kenya, with SP only used as an IPTp, in accordance with WHO 
 guidelines1,33. Monotherapy treatments have been largely phased out, with artemisinin only used in combina-
tion therapies and chloroquine no longer available over the counter in pharmacies or as a first-line treatment. 
Despite its discontinued use, resistance markers for chloroquine resistance still persist in these Lake Victoria 
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isolates and much of East Africa, apart from Malawi which has since seen the return of chloroquine sensitivity 
in its parasite populations following earlier changes to treatment  policies34,35. It is anticipated that chloroquine 
sensitivity will return to parasite populations across Africa when drug selection pressure is completely removed, 
but the slow reduction in resistance marker frequencies suggests there is a low or negligent fitness cost associated 
with maintaining these polymorphisms.
A handful of resistance markers for SP were identified in the Lake Victoria isolates, with three established 
biomarkers (N51I and S108N on Pfdhfr; K540E on Pfdhps) observed to be almost fixed. The continued use of SP 
as an IPTp is likely providing enough driving pressure to maintain these polymorphisms within Lake Victoria 
and in parasite populations across the continent. However, given the high frequencies of these biomarkers, it is 
also possible that their presence does not come at a large fitness cost to the parasite. The S160N/T mutation in 
Pfap2mu, first documented in Kenyan children following delayed parasite clearance by ACT, was observed to be 
present at similar frequencies to the rest of East Africa and at a lower frequency than in West  Africa16. Although 
further in vivo and in vitro studies are required to confirm the role polymorphisms in Pfap2mu play in resist-
ance to ACTs, the presence of this mutation highlights the importance of monitoring parasite populations in 
high-transmission regions for the emergence of existing and novel resistance methods that could compromise 
the efficacy of ongoing malaria control and elimination strategies in Africa.
Due to the nature of working with field isolates, there were some limitations with this study. Most samples 
collected under this survey campaign are from asymptomatic individuals who generally have low parasitaemia 
levels, which often results in poor quality parasite DNA following extraction from blood spots. This issue was 
especially apparent in samples collected from Ngodhe island, where many cases of malaria are sub-microscopic 
and only detectable using  PCR12. Due to these limitations, asymptomatic infections, in general, tend to be under-
represented in studies aimed at characterizing the genetic and genomic variation of malaria parasites, despite the 
fact they make up a majority of infections  worldwide36. To overcome this, we applied selective whole genome 
amplification methodologies to select and amplify the parasite DNA in these field  isolates8,37,38. This approach 
enabled us to increase parasite DNA concentrations in many samples that would normally not meet the require-
ments for whole genome sequencing, allowing us to provide the first baseline of the genomic variation and popu-
lation dynamics of the Lake Victoria basin, with the potential for roll-out in other regions in Africa or globally.
Despite the progress made over the last decade, the reduction in malaria incidence rates and deaths has 
decelerated since 2016 and progress towards global malaria eradication has slowed. These trends, combined with 
setbacks to malaria control programmes, for example, due to the COVID-19 pandemic, have highlighted the 
need to generate comprehensive pictures of the epidemiology and structural variation of parasite populations. 
In high transmission regions, it is important to monitor the efficacy of current malaria control programmes 
and highlight potential challenges that may undermine their success. Here, we provided a baseline level of the 
genomic diversity of P. falciparum in the Lake Victoria basin of Kenya, a region whose genomic diversity has been 
previously unexplored. The application of sequencing technologies in malaria endemic regions will assist clinical 
management and disease control through surveillance activities. Known and putative drug resistance markers 
in established loci and population-specific markers are detectable using low-cost sequencing-based approaches 
(e.g., amplicon-based), suitable for a low resource setting. Large-scale approaches using (portable) whole genome 
sequencing and analysis will assist with understanding the transmission of malaria and provide insights into 
circulating drug resistance. Such insights will inform the deployment of antimalarial drugs and disease control 
tools and strategies in a region with currently high malaria burden, but with the potential for disease elimination.
Materials and methods
Study site selection. Parasite DNA sample collection for this study began in 2014 from several inhabited 
islands in Lake Victoria (Mfangano, N = 36; Ngodhe, N = 1) and the mainland sub-county of Homa Bay County, 
Suba district (Ungoye, N = 11) (Supplementary Fig. S4). Sample collection in this region was performed within 
an ongoing bi-annual survey, in accordance with the seasonal malaria prevalence. This seasonal transmission 
is linked to long (March–May) and short (October–December) rainy seasons. A peak in malaria prevalence is 
generally observed in June following the long rainy season and remains steady between September and February.
Permission to conduct this study was obtained from the Mount Kenya University Independent Ethics and 
Research Committee (MKU-IERC) (Approval reference: P609/10/2014) and the Ethics Committee at Osaka 
City University (Approval number: 3206) and performed in accordance with relevant guidelines and regulations. 
Workshops and sensitisation meetings were carried out with communities in order to seek community consent 
to study participation. Written informed consent was obtained from all study participants whose parasite DNA 
was used in this study.
Study population characteristics. This region of the Lake Victoria basin is occupied by both Luo and 
Suba ethnic groups, with Ngodhe occupied entirely by the former. The Luo ethnic group are generally migrant 
fishermen, while the Suba ethnic group rely more heavily on subsistence  farming4. The main mode of transporta-
tion on the lake are dugout boats, but a ferry service is also in place, operating regularly to bring merchants and 
workers between the islands and the mainland commercial hub, Mbita.
Malaria species identification. Malaria species identification was carried out by microscopy, following 
WHO guidelines, at the Nagasaki University research station in Kenya by trained microscopists and confirmed 
at Osaka City University and LSHTM Malaria Reference Laboratory using established nested PCR  assays39,40.
Whole genome sequencing and bioinformatics. Twenty-nine isolates (collected years 2014 to 2015) 
were sequenced from DNA extracted from short-term (2–3month) cultures using Illumina MiSeq technology 
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with 300 bp paired end kits organised by Nagasaki University. The DNA for a further twenty-nine isolates (col-
lected year 2020) was extracted from filter papers and amplified using an established selective whole genome 
amplification (SWGA) primer set and  protocols8,41, before being sequenced on Illumina MiSeq platform with 
300 bp paired end kits at the LSHTM. All raw sequence data, following whole genome sequencing (WGS), was 
mapped to the Pf3D7 (P. falciparum) reference (version 3) genome using bwa-mem software (default param-
eters). SNPs and short insertions and deletions (indels) were called using the samtools and GATK software 
 suites28,29. SNPs occurring in non-unique, highly variable (e.g., var genes), low quality or low coverage regions 
were discarded. Mixed call SNPs were assigned genotypes determined by a ratio of coverage in which nucleotide 
calls were 80% or higher. Samples with a coverage across the genome averaging less than 5 were not included in 
any analysis. Of the 58 samples sequenced, 10 were removed, leaving a total of 784 isolates in the final analyses.
Characterising genomic variants and population genetic analyses. Population structure was 
investigated using neighbour-joining tree and principal component analyses, both using pairwise genetic dis-
tance matrices based on SNPs. Nucleotide diversity and population differentiation (FST) metrics were calculated 
using the pegas R  library42. The visualization and annotation of neighbour-joining trees was performed using 
iTOL43. The variants in drug-resistance genes were extracted from the sequence alignments, and annotated using 
snpEff software, which determined the type of mutation (e.g. non-synonymous, synonymous, or intergenic), 
as well as the codon and protein shift caused by any non-synonymous mutations and the projected impact of 
the  polymorphism44. Grouping of samples into regional populations (e.g., Lake Victoria islands, Lake Victoria 
mainland, and East Africa) was determined based on patterns or human and vector migration within the region, 
alongside input from collaborators. WGS data from isolates collected on Mfangano island matched closely with 
the single isolate obtained from Ngodhe island, and were therefore combined into one population for further 
analysis.
The R-based Tess3r package, which estimates ancestry proportions by modelling on continuous genetic varia-
tion across space, was used to calculate admixture based on the spatial modelling of allele sharing using genome-
wide SNPs and geographical coordinates from sampling sites (specified in the Pf3k dataset or recorded during 
sample collection for Lake Victoria isolates)45–47. An optimum K value for ancestral admixture coefficients was 
estimated as 5 from a cross-validation of 1 to 10 dimensions of eigenvalue decay. Bi-allelic sites were included in 
this analysis, while mixed calls were imputed to alternative and missing calls were left unchanged. The default 
spatial regularisation parameter (σ = 1) was used, which attributes equal weight to the loss  and penalty functions. 
Tess3r was run 50 times for K5 to K10 and the best Q matrix of ancestry coefficients for every isolate was retained. 
This analysis used the alternating projected least squares algorithm (APLS; method = “projected.ls”). Plots were 
visualised using the R-based package ggplot2 and surfaces were interpolated using the R-based package Krig48–50.
Multi-clonality, or within-host infection complexity, was measured by calculating the FWS metric, using an 
in-house script, which assesses within-host diversity in relation to the local population diversity in order to 
characterise the risk of out-crossing/inbreeding by estimating the fixation of alleles, on a scale of 0 to 1, within 
each  infection14. Based on previous studies, an FWS ≥ 0.95 is considered highly indicative of a clonal infection.
Identity-by-descent (IBD) was used to assess connectivity between parasites within the Lake Victoria region 
and between subpopulations within the region. This was achieved by estimating the pairwise fraction of shared 
ancestry between genomic segments, the “IBD fraction”, that were inferred to have descended from a recent com-
mon ancestor without undergoing any intervening recombination. These IBD fractions were calculated using 
the hmmIBD software which accounts for recombination using a hidden Markov model-based  approach51. The 
rate of recombination for P. falciparum is estimated to be 13.5 Kb per centiMorgan (cM), which should result in 
chromosomal crossover events occurring at an average rate of approximately 1% per generation.
Regions of the genome under putative positive directional selection were scanned using population-based 
measures of haplotype diversity within (iHS) or between (XP-EHH) populations using the R-based rehh 
 package52,53.
Data availability
Public accession numbers for raw sequence data analysed are contained in SRA studies ERP000190 and 
ERP000199, as well as being accessible from the Pf3k project website (https:// www. malar iagen. net/ proje cts/ 
pf3k). Lake Victoria raw sequences are available from the EBI SRA (Project accession PRJEB46180) and DDBJ 
(BioProject Accession Number PRJDB12148).
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